5HOFF P M,ANSARI R,BATIST G,et al.Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer:results of a randomized phase Ⅲ study[J].J Clin Oncol,2001,19(8):2282-2292.
6ANONYMOUS.Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer.Adopted on May 17,1996 by the American Society of Clinical Oncology[J].J Clin Oncol,1996,14(10):2843-2877.
7LOCKER G Y,HAMILTON S,HARRIS J,et al.ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer[J].J Clin Oncol,2006,24(33):5313-5327.
8HORWICH A,PECKHAM M J.Transient tumor marker elevation following chemotherapy for germ cell tumors of the testis[J].Cancer Treat Rep,1986,70(11):1329-1331.
9LOPRINZI C L,TORMEY D C,RASMUSSEN P,et al.Prospective evaluation of carcinoembryonic antigen levels and alternating chemotherapeutic regimens in metastatic breast cancer[J].J Clin Oncol,1986,4(1):46-56.
10Goldstein MJ, Mitchell EP,Carcinoembryonic antigen in the staging and follow up of patients with coloreetal cancer[J]. Cancer investi gation,2005,23(4)338-351.
